LIXTE BIOTECHNOLOGY HOLDINGS INC (LIXT)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.43-0.45%
Close 2026-07-28 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · LIXT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | — | — | — | — | — | — | — | — | — | — | 0.2 | — | 0.0 | 0.0 | 0.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | — | 0.2 | — | 0.0 | 0.0 | 0.0 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 0.5 | 0.3 | 0.7 | 0.9 | 1.3 | 1.7 | 1.2 | 0.8 | 0.0 | 0.5 | 0.9 | 2.1 | 1.1 | 0.9 | 1.0 | 1.3 |
| Operating Income | (8.0) | (5.1) | (3.6) | (5.1) | (6.3) | (6.7) | (3.3) | (2.5) | (2.1) | (1.8) | (2.1) | (2.6) | (2.4) | (1.4) | (2.1) | (1.9) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 |
| Interest & Investment Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | (0.0) | (0.0) | 0.0 | (0.0) | — | — | — | — | — | — | (0.0) | (0.0) | (0.0) |
| Income Tax Expense | — | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (8.9) | (6.1) | (3.6) | (5.1) | (6.3) | (6.7) | (3.3) | (2.4) | (2.1) | (1.8) | (2.1) | (2.9) | (2.8) | (1.4) | (3.6) | (2.1) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.66) | — | (1.59) | (2.66) | (3.99) | (0.50) | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (0.66) | (1.26) | (1.59) | (2.66) | (3.99) | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 13.5 | — | 2.2 | 1.9 | 1.6 | 13.5 | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 13.5 | 4.8 | 2.2 | 1.9 | 1.6 | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBIT | (8.0) | (5.1) | (3.6) | (5.1) | (6.3) | (6.7) | (3.3) | (2.5) | (2.1) | (1.8) | (2.1) | (2.6) | (2.4) | (1.4) | (2.1) | (1.9) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.